WEE1 Kinase As a Target for Cancer Therapy
- PMID: 26215953
- DOI: 10.1200/JCO.2015.62.2290
WEE1 Kinase As a Target for Cancer Therapy
Comment on
-
Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors.J Clin Oncol. 2015 Oct 20;33(30):3409-15. doi: 10.1200/JCO.2014.60.4009. Epub 2015 May 11. J Clin Oncol. 2015. PMID: 25964244 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials